On Wednesday, GitLab Cl A hit an important technical milestone, with its Relative Strength (RS) Rating climbing into the 80-plus percentile with an upgrade to 85, up from 80 the day before.
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
History shows that the market's biggest winners typically have an 80 or better RS Rating as they begin their biggest price moves.
Looking For The Best Stocks To Buy And Watch? Start Here
GitLab Cl A is building a cup with handle with a 68.69 buy point. See if it can clear the breakout price in heavy trade.
Earnings growth rose in the company's most recent report from 0% to 1,400%, but sales fell from 33% to 31%. The company is expected to report its latest performance numbers on or around Dec. 5.
GitLab Cl A earns the No. 2 rank among its peers in the Computer-Technical Services industry group. Dave is the No. 1-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
